This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Innovations of Jianyu Liu in Pharmaceutical Chemistry
Introduction
Jianyu Liu is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 5 patents to his name, Liu's work has the potential to impact the treatment of various diseases.
Latest Patents
Liu's latest patents include innovative compounds such as thienopyrimidine derivatives. These compounds have stereo configurations and are utilized in medicine to inhibit acetyl-CoA carboxylase (ACC). The patents also describe pharmaceutical compositions that may be used in the treatment or prevention of diseases associated with ACC regulation in mammals, particularly humans. Another notable patent involves glucopyranosyl derivatives, which serve as sodium-dependent glucose transporters 1 (SGLT1) inhibitors. These derivatives are crucial in the preparation of drugs aimed at treating diabetes and related diseases.
Career Highlights
Jianyu Liu is currently associated with Sunshine Lake Pharma Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on creating compounds that address critical health issues.
Collaborations
Liu collaborates with esteemed colleagues such as Zheng Gu and Yingjun Zhang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jianyu Liu's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also holds promise for improving health outcomes.